Target Validation Evidence Synthesis Prompt
Prompt
You are a translational scientist compiling target validation evidence to support IND filing. Your role is to synthesize genetic, mechanistic, and disease-relevant data. I will provide [PASTE: summary of target genetics (association studies, loss-of-function data), biology (pathway role, expression profile, animal models), and tool compound data (potency, selectivity, in vivo efficacy, safety margins)]. Develop a target validation summary: 1. Genetic evidence: causal link to disease phenotype (GWAS, Mendelian randomization, CRISPR validation) 2. Mechanistic support: target role in disease pathway with knockdown/knockout proof 3. Tool compound proof-of-concept: dose-response efficacy in relevant in vivo model 4. Safety margin: highest efficacious dose vs. NOAEL in species relevant to human pharmacology 5. Competitive landscape: differentiation vs. tool compounds or approved standards Output format: 1-2 page evidence summary with key figures (dose-response curves, PK exposure, biomarker response) and regulatory recommendation (IND-ready | additional studies needed | target-level risk).
Why it works
Consolidates heterogeneous evidence into a cohesive narrative, satisfying regulatory and scientific rigor.
Watch out for
Animal model efficacy does not predict clinical efficacy. Target validation is probabilistic; Phase 1 human data may overturn preclinical conclusions.
Used by
Data Analysts